This program will review emerging evidence on the nutritional implications of incretin-based therapies (IBTs) in individuals with obesity and diabetes. It explores the association between IBTs, nutrient gaps, and muscle health, and presents targeted nutrition strategies to address these concerns.
The course emphasizes practical, evidence-based approaches to support long-term patient health. Emerging evidence on diabetes-specific formulas (DSFs) and beta-hydroxy-beta-methylbutyrate (HMB) will be explored.
- Tuesday, September 30 and Tuesday, December 9
Part 1: Nutrient Gaps and New Guidelines with IBTs - Wednesday, October 1 and Wednesday, December 10
Part 2: Supporting Muscle Health with IBTs - Thursday, October 2 and Thursday, December 11
Part 3: Translating Knowledge into Clinical Practice
- Describe the factors that contribute to obesity as a chronic disease
- Discuss the current landscape of incretin-based therapies for weight management and concurrent nutrition recommendations for obesity and diabetes
- Review the importance of muscle health and evidence-based nutrition therapies for patients with obesity and diabetes.
For more information, view the webinar series flyer.
Register today!
Abbott Nutrition Health Institute is a proud Partner in Health of the Ohio Academy of Family Physicians, and an online resource that contains links to organizations that provide patient education and high-value tools designed to support family physicians and their care teams in delivering optimal frontline care.